4:17 PM ET
8-K
Investor Presentation
iBio Investor Presentation
iBio, Inc. has updated its corporate presentation for use in meetings with investors and analysts. The presentation, titled 'Breakthrough Antibodies for Obesity and Cardiometabolic Diseases', highlights the company's strategic focus and product candidate pipeline as of September 2026.